Orchestra BioMed Holdings Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -113.7% | – | -21.9% | -4.4% | +1,169.2% | |
| – | +37.2% | +61.8% | -42.2% | +9.7% | -6.9% | |
| – | -117.7% | – | -19.8% | -5.4% | +1,267.8% | |
| – | -4.4% | +70.2% | +54.1% | +26.6% | +35.9% | |
| – | -26.8% | +77.0% | +44.3% | +18.1% | +12.5% | |
| – | -14.4% | +72.3% | +50.8% | +23.4% | +27.5% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | -64.4% | -123.9% | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.